The government has reached an in-principle agreement to purchase doses of a Covid-19 vaccine for the entire population.
If all goes to plan, the first doses - up to 2 million - would be delivered in the second half of 2021.
The government would then have the option to purchase up to 3 million additional doses, which would be delivered throughout 2022.
Developed by Janssen Pharmaceutica, the shot uses a harmless cold virus to prompt an immune response - which researchers hope will innoculate recipients against Covid-19.
That's a different strategy to the Moderna and Pfizer vaccines, which have also announced promising results.
Megan Woods is the Minister of Research, Science and Innovation.
[audio_play]
Pharmaceutical company Pfizer has announced its Covid-19 vaccine is 95 percent effective in preventing the coronavirus, with no safety concerns.
Last week, Pfizer's preliminary data showed the vaccine offered 90 percent protection against Covid-19.
Pfizer says it will seek US Food and Drug Administration emergency use authorization "within days".